Page 108 - rcv31n3.vp

El año 2015 en cardiología: arritmias y tratamiento con dispositivos Revista Uruguaya de Cardiología
Jan Steffel, Pierre Jais, Gerhard Hindricks Volumen 31 | nº 3 | Diciembre 2016

death of the European Society of Cardiology (ESC) rence to automatic wireless remote monitoring and
endorsed by: Association for European Paediatric survival in pacemaker and defibrillator patients. J
and Congenital Cardiology (AEPC). Eur Heart J Am Coll Cardiol 2015;65:2601–10.
2015; doi:10.1093/eurheartj/ehv316. Published onli-
43. Abraham WT, Stevenson LW, Bourge RC, Lin-
ne ahead of print 29 August 2015.
denfeld JA, Bauman JG, Adamson PB;
36. Ritter P, Duray GZ, Steinwender C, Soejima K, CHAMPION Trial Study Group. Sustained effi-
Omar R, Mont L, et al; Micra Transcatheter Pa- cacy of pulmonary artery pressure to guide adjust-
cing Study Group. Early performance of a miniatu- ment of chronic heart failure therapy: complete fo-
rized leadless cardiac pacemaker: the MICRA Trans- llow-up results from the CHAMPION randomised
catheter Pacing Study.EurHeartJ2015;36:2510–9 trial. Lancet 2015. [Epub ahead of print].
37. Reynolds D, Duray GZ, Omar R, Soejima K, 44. Brisben AJ, Burke MC, Knight BP, Hahn SJ,
Neuzil P, Zhang S, et al; Micra Transcatheter Herrmann KL, Allavatam V, et al. A new algo-
Pacing Study Group. A leadless intracardiac rithm to reduce inappropriate therapy in the S-ICD
transcatheter pacing system. N Engl J Med2015. system. J Cardiovasc Electrophysiol 2015;26:417–23.
[Epub ahead of print].
45. Lambiase PD, Barr C, Theuns DA, Knops R,
38. Reddy VY, Exner DV, Cantillon DJ, Doshi R, Neuzil P, Johansen JB, et al; Investigators E.
Bunch TJ, Tomassoni GF, et al; LEADLESS II Worldwide experience with a totally subcutaneous
Study Investigators. Percutaneous implantation implantable defibrillator: early results from the ef-
of an entirely intracardiac leadless pacemaker. N fortless S-ICD registry. Eur Heart J 2014;35: 1657–
Engl J Med 2015;373:1125–35. 65.
39. Bansch D, Bonnemeier H, Brandt J, Bode F, 46. Knops RE, Brouwer TF, Barr CS, Theuns DA,
Svendsen JH, Taborsky M, et al; NORDIC ICD Boersma L, Weiss R, et al; Investigators E. The
Trial Investigators. Intra-operative defibrillation learning curve associated with the introduction of
testing and clinical shock efficacy in patients with the subcutaneous implantable defibrillator. Europa-
implantable cardioverter-defibrillators: the ce 2015; doi:10.1093/europace/euv299.
NORDIC ICD randomized clinical trial. Eur Heart J
47. Burke MC, Gold MR, Knight BP, Barr CS,
2015;36:2500–7.
Theuns DA, Boersma LV, et al. Safety and effi-
40. Healey JS, Hohnloser SH, Glikson M, Neuzner cacy of the totally subcutaneous implantable defibri-
J, Mabo P, Vinolas X, et al; Shockless IMPLant llator: 2-year results from a pooled analysis of the
Evaluation [SIMPLE] Investigators. Cardiover- IDE study and effortless registry. J Am Coll Cardiol
ter defibrillator implantation without induction of 2015;65: 1605–15.
ventricular fibrillation: a single-blind, noninferio-
48. Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S,
rity, randomised controlled trial (SIMPLE). Lancet
MacKecknie B, et el. Use of the wearable cardio-
2015;385:785–91.
verter defibrillator in high-risk cardiac patients: data
41. Varma N, Ricci RP. Telemedicine and cardiac im- from the prospective registry of patients using the
plants: what is the benefit? Eur Heart J 2013;34: wearable cardioverter defibrillator (WEARIT-II re-
1885-95. gistry). Circulation 2015;132:1613-9.
42. Varma N, Piccini JP, Snell J, Fischer A, Dalal
N, Mittal S. The relationship between level of adhe-

460